Back

Symptom Driven ICS/LABA - Adolescent Study

Official Title

Symptom-driven ICS/LABA therapy for adolescents with asthma non-adherent to daily maintenance inhalers

Study Details

The purpose of this study is to better understand what adolescent asthma patients' views on taking inhalers are, and assess if patients would have better asthma control and be more adherent to a different inhaler regimen than what is currently prescribed.

Principal Investigator

Dr. James Krings

IRB Number

202203033

Eligibility

1. Participants must be 12 to 17 years
2. Participants must have asthma and must be prescribed a maintenance inhaler

Volunteer Information

For more information about this study, contact Volunteer for Health at:

Back